Bristol-Myers Squibb Company (BRM)
XDUS
Delayed Data
Oct 12, 2026, 06:00 AM
Day's Range
51.0952 wk Range
36.61Overview - BRM - Bristol-Myers Squibb Company
Key Statistics
Valuation
Enterprise Value
36.93B
P/E (Trailing)
‪16.07‬
PEG Ratio
‪0.10‬
Price / Book
‪5.10‬
EV / EBITDA
‪1.85‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪71.08%‬
Operating Margin
‪23.27%‬
Return on Assets
‪7.83%‬
Return on Equity
‪38.11%‬
Ownership
Shares Outstanding
2.04B
Price stats
50-Day Avg
‪55.74‬
200-Day Avg
‪50.97‬
Dividends
Frequency
Quarterly
Peers - BRM - Bristol-Myers Squibb Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- BRMXDUSBristol-Myers Squibb Company+31.19%52-week change16.07P/E (Trailing)‪71.08%‬Profit Margin
- 6MKXDUSMerck & Co., Inc.+43.34%52-week change17.66P/E (Trailing)‪74.80%‬Profit Margin
- IDPXDUSBiogen Inc.+40.40%52-week change23.81P/E (Trailing)‪75.69%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+38.89%52-week change-11.74P/E (Trailing)‪58.75%‬Profit Margin
- BAYNXDUSBayer AG+38.13%52-week change-12.00P/E (Trailing)‪58.75%‬Profit Margin
- AMGXDUSAmgen Inc.+32.95%52-week change26.92P/E (Trailing)‪67.24%‬Profit Margin
- 7XPXDUSOrganon & Co.+31.68%52-week change17.05P/E (Trailing)‪53.29%‬Profit Margin
Profile Summary - BRM - Bristol-Myers Squibb Company
About
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for serious diseases. Bristol-Myers Squibb Company focuses on major therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and neuroscience, serving…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
